Prokidney (PROK) Non-Current Deferred Tax Liability (2021 - 2023)
Prokidney's (PROK) quarterly Non-Current Deferred Tax Liability came in at $1.5 million in Q4 2023, down 13.29% year-on-year from $1.7 million in Q4 2022, and down 13.29% on a QoQ basis from $1.7 million in Q4 2022.
Prokidney (PROK) Non-Current Deferred Tax Liability (2021 - 2023) Analysis & Trends
Prokidney (PROK) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $1.5 million in Q4 2023.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 13.29% year-over-year to $1.5 million in Q4 2023; TTM through Dec 2023 was $1.5 million, a 13.29% decrease from a year earlier, with the FY2023 full-year figure at $1.5 million, down 13.29% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2023 stood at $1.5 million, down from $1.7 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for PROK reached as high as $1.7 million in Q4 2022 and fell as low as $47000.0 in Q4 2021.
- Historically, Non-Current Deferred Tax Liability has averaged $1.1 million across 3 years, with a median of $1.5 million in 2023.
- Across the five-year window, Non-Current Deferred Tax Liability jumped 3534.04% in 2022 and fell 13.29% in 2023, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $47000.0 in 2021, then soared by 3534.04% to $1.7 million in 2022, then dropped by 13.29% to $1.5 million in 2023.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $1.5 million in Q4 2023, $1.7 million in Q4 2022, and $47000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 47,000.00 |
| Dec 31, 2021 | 47,000.00 |